These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37021586)

  • 1. Discovery of 5-alkyl-2-pyrazol-oxazolidin-4-one derivatives as novel hepatitis B virus capsid assembly modulators.
    Guan M; Wang Y; Wang Y; Chen N; Shi S; Sheng R
    Arch Pharm (Weinheim); 2023 Jun; 356(6):e2200592. PubMed ID: 37021586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle.
    Lahlali T; Berke JM; Vergauwen K; Foca A; Vandyck K; Pauwels F; Zoulim F; Durantel D
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrimidotriazine derivatives as selective inhibitors of HBV capsid assembly.
    Toyama M; Sakakibara N; Takeda M; Okamoto M; Watashi K; Wakita T; Sugiyama M; Mizokami M; Ikeda M; Baba M
    Virus Res; 2019 Oct; 271():197677. PubMed ID: 31376401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Based Discovery of
    Yang Y; Yan Y; Yin J; Hu J; Cai X; Hu J; Xia J; Wang K; Tang N; Huang L
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based Design of Novel Hepatitis B Virus Capsid Assembly Modulators.
    Detta E; Corcuera A; Urban A; Goldner T; Bonsmann S; Engel F; May MM; Buschmann H; Fianchini M; Alza E; Pericàs MA; Pushkarev PA; Varenyk AO; Yakovyuk TY; Homon AA; Sokoliuk PA; Smaliy R; Donald A
    Bioorg Med Chem Lett; 2023 Sep; 93():129412. PubMed ID: 37499987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of New Small Molecule Hits as Hepatitis B Virus Capsid Assembly Modulators: Structure and Pharmacophore-Based Approaches.
    Senaweera S; Du H; Zhang H; Kirby KA; Tedbury PR; Xie J; Sarafianos SG; Wang Z
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33925540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of (1
    Wang C; Pei Y; Wang L; Li S; Jiang C; Tan X; Dong Y; Xiang Y; Ma Y; Liu G
    J Med Chem; 2020 Jun; 63(11):6066-6089. PubMed ID: 32421339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of novel dihydrobenzodioxine derivatives as HBV capsid protein inhibitors.
    Liu L; Wang M; Li C; Han X; Xie Y; Feng K; Zhang L; Chen Y; Jia H
    Bioorg Chem; 2022 Nov; 128():106052. PubMed ID: 35921789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis, and Biological Evaluation of Novel Thioureidobenzamide (TBA) Derivatives as HBV Capsid Assembly Modulators.
    Wang M; Zhang J; Dou Y; Liang M; Xie Y; Xue P; Liu L; Li C; Wang Y; Tao F; Zhang X; Hu H; Feng K; Zhang L; Wu Z; Chen Y; Zhan P; Jia H
    J Med Chem; 2023 Oct; 66(20):13968-13990. PubMed ID: 37839070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of benzimidazole-based compounds as novel capsid assembly modulators for the treatment of HBV infection.
    Du K; Wang X; Bai Y; Zhang X; Xue J; Li S; Xie Y; Sang Z; Tang Y; Wang X
    Eur J Med Chem; 2024 May; 271():116402. PubMed ID: 38636128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel HBV capsid assembly modulators by structure-based virtual screening and bioassays.
    Wang Y; Wang Z; Liu J; Wang Y; Wu R; Sheng R; Hou T
    Bioorg Med Chem; 2021 Apr; 36():116096. PubMed ID: 33721800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization and Synthesis of Pyridazinone Derivatives as Novel Inhibitors of Hepatitis B Virus by Inducing Genome-free Capsid Formation.
    Lu D; Liu F; Xing W; Tong X; Wang L; Wang Y; Zeng L; Feng C; Yang L; Zuo J; Hu Y
    ACS Infect Dis; 2017 Mar; 3(3):199-205. PubMed ID: 27989113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors.
    Jia H; Yu J; Du X; Cherukupalli S; Zhan P; Liu X
    Eur J Med Chem; 2020 Sep; 202():112495. PubMed ID: 32712535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of N-sulfonylpiperidine-3-carboxamide derivatives as capsid assembly modulators inhibiting HBV in vitro and in HBV-transgenic mice.
    Yin J; Feng Z; Li Z; Hu J; Hu Y; Cai X; Zhou H; Wang K; Tang N; Huang A; Huang L
    Eur J Med Chem; 2023 Mar; 249():115141. PubMed ID: 36709646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly.
    Wu S; Zhao Q; Zhang P; Kulp J; Hu L; Hwang N; Zhang J; Block TM; Xu X; Du Y; Chang J; Guo JT
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and antiviral profile of new sulfamoylbenzamide derivatives as HBV capsid assembly modulators.
    Ivanova Bencheva L; Donnici L; Ferrante L; Prandi A; Sinisi R; De Matteo M; Randazzo P; Conti M; Di Lucia P; Bono E; Giustini L; Vittoria Orsale M; Patsilinakos A; Monteagudo E; Iannacone M; Summa V; Guidotti LG; De Francesco R; Di Fabio R
    Bioorg Med Chem Lett; 2022 Oct; 73():128904. PubMed ID: 35868496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of hepatitis B virus capsid assembly inhibitors leading to a heteroaryldihydropyrimidine based clinical candidate (GLS4).
    Ren Q; Liu X; Luo Z; Li J; Wang C; Goldmann S; Zhang J; Zhang Y
    Bioorg Med Chem; 2017 Feb; 25(3):1042-1056. PubMed ID: 28082068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel hepatitis B virus capsid assembly modulator QL-007 inhibits HBV replication and infection through altering capsid assembly.
    Xi J; Gu Z; Sun C; Chen Z; Zhang T; Chen R; Liu T; Liao H; Zou J; Yang D; Xu Q; Wang J; Wei G; Cheng Z; Lu F; Chen X
    Antiviral Res; 2023 Oct; 218():105715. PubMed ID: 37683938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells.
    Huber AD; Wolf JJ; Liu D; Gres AT; Tang J; Boschert KN; Puray-Chavez MN; Pineda DL; Laughlin TG; Coonrod EM; Yang Q; Ji J; Kirby KA; Wang Z; Sarafianos SG
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29669885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-Oxooctahydroquinoline-1(2H)-carboxamides as hepatitis B virus (HBV) capsid core protein assembly modulators.
    Hwang N; Ban H; Wu S; McGuire K; Hernandez E; Chen J; Zhao Q; Suresh M; Blass B; Viswanathan U; Kulp J; Chang J; Clement J; Menne S; Guo JT; Du Y
    Bioorg Med Chem Lett; 2022 Feb; 58():128518. PubMed ID: 34979256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.